Skip to main content

Table 1 Model input for effectiveness data

From: Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective

 

BRVO

CRVO

 

Ranibizumab

Laser Photocoagulation

Ranibizumab

Observation

Month 1

BLOSSOM

BLOSSOM

CAMELLIA

CAMELLIA

Month 2–6

BLOSSOM

BLOSSOM

CAMELLIA

CAMELLIA

Months 7–12

BLOSSOM

BLOSSOM

CAMELLIA

CAMELLIA

Year 2

Horizon

Horizon

Horizon

Horizon

Year 3

Natural History

Natural History

Natural History

Natural History